Biggest changeGeneral and administrative expenses are not allocated to the reportable segments and are included in “All Other”: Home Health and Hospice Services Senior Living Services All Other Total (In thousands) Segment GAAP Financial Measures: Year Ended December 31, 2023 Revenue $ 394,464 $ 150,427 $ — $ 544,891 Segment Adjusted EBITDAR from Operations $ 65,606 $ 45,294 $ (31,704) $ 79,196 Year Ended December 31, 2022 Revenue $ 342,249 $ 130,992 $ — $ 473,241 Segment Adjusted EBITDAR from Operations $ 61,827 $ 37,563 $ (31,435) $ 67,955 Year Ended December 31, 2021 Revenue $ 309,570 $ 130,124 $ — $ 439,694 Segment Adjusted EBITDAR from Operations $ 55,565 $ 37,517 $ (26,208) $ 66,874 The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to income from operations: Year Ended December 31, 2023 2022 2021 (In thousands) Segment Adjusted EBITDAR from Operations (a) $ 79,196 $ 67,955 $ 66,874 Less: Depreciation and amortization 5,130 4,900 4,784 Rent—cost of services 39,759 38,018 40,863 Other (expense) income 339 (31) (24) Adjustments to Segment EBITDAR from Operations: Less: Costs at start-up operations (b) 102 1,435 1,045 Share-based compensation expense (c) 5,565 3,363 10,040 Acquisition related costs and credit allowances (d) 476 731 80 Transition services costs (e) — — 2,008 Costs associated with transitioning operations (f) 612 6,103 2,835 Unusual or non-recurring charges (g) 2,575 1,297 — Add: Net income (loss) attributable to noncontrolling interest 531 600 (548) Income from operations $ 25,169 $ 12,739 $ 4,695 36 Table of Contents (a) Segment Adjusted EBITDAR from Operations is net income attributable to the Company's reportable segments excluding interest expense, provision for income taxes, depreciation and amortization expense, rent, and, in order to view the operations performance on a comparable basis from period to period, certain adjustments including: (1) costs at start-up operations, (2) share-based compensation expense, (3) acquisition related costs and credit allowances, (4) transition services costs, (5) costs associated with transitioning operations, (6) unusual, non-recurring or redundant charges, and (7) net income (loss) attributable to noncontrolling interest.
Biggest changeGeneral and administrative expenses are not allocated to the reportable segments: Home Health and Hospice Services Senior Living Services All Other Total Year Ended December 31, 2024 Segment Revenue $ 515,344 $ 174,767 $ 5,129 $ 695,240 Segment Cost of Services 427,635 123,107 Segment Adjusted EBITDAR from Operations $ 87,709 $ 51,660 $ 139,369 Year Ended December 31, 2023 Segment Revenue $ 385,652 $ 148,198 $ 11,041 $ 544,891 Segment Cost of Services 320,046 102,904 Segment Adjusted EBITDAR from Operations $ 65,606 $ 45,294 $ 110,900 Year Ended December 31, 2022 Segment Revenue $ 337,371 $ 126,758 $ 9,112 $ 473,241 Segment Cost of Services 275,544 89,195 Segment Adjusted EBITDAR from Operations $ 61,827 $ 37,563 $ 99,390 The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to income from operations: 2024 2023 2022 Segment Adjusted EBITDAR from Operations (a) $ 139,369 $ 110,900 $ 99,390 Less: Unallocated corporate expenses 43,587 31,704 31,435 Less: Depreciation and amortization 6,119 5,130 4,900 Rent—cost of services 43,029 39,759 38,018 Other income 207 339 (31) Adjustments to Segment EBITDAR from Operations: Less: Costs at start-up operations (b) 137 102 1,435 Share-based compensation expense (c) 8,242 5,565 3,363 Acquisition related costs and credit allowances (d) 1,278 476 731 Costs associated with transitioning operations (e) (570) 612 6,103 Unusual, non-recurring or redundant charges (f) 1,004 2,575 1,297 Add: Net income attributable to noncontrolling interest 1,780 531 600 Income from operations $ 38,116 $ 25,169 $ 12,739 35 Table of Contents (a) Segment Adjusted EBITDAR from Operations is net income attributable to the Company's reportable segments excluding interest expense, provision for income taxes, depreciation and amortization expense, rent, unallocated corporate and administrative expenses, and, in order to view the operations performance on a comparable basis from period to period, certain adjustments including: (1) costs at start-up operations, (2) share-based compensation expense, (3) acquisition related costs and credit allowances, (4) costs associated with transitioning operations, (5) unusual, non-recurring or redundant charges, and (6) net income (loss) attributable to noncontrolling interest.
The amounts reported exclude rent and depreciation and amortization expense related to such operations and include legal settlement costs associated with one of the entities transitioned to Ensign.
The amounts reported exclude rent and depreciation and amortization expense related to such operations and include legal settlement costs associated with one of the entities transitioned to Ensign.
During January 2022, affiliates of the Company entered into Transfer Agreements with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the “Transaction”) from affiliates of the Company to affiliates of Ensign.
During January 2022, affiliates of the Company entered into Transfer Agreements with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the “Transaction”) from affiliates of the Company to affiliates of Ensign.
The closing of the Transaction was completed in two phases with the transfer of two operations on March 1, 2022 and the remainder transferred on April 1, 2022. The amount above represents the net impact on revenue and cost of service attributable to all of the transferred entities.
The closing of the Transaction was completed in two phases with the transfer of two operations on March 1, 2022 and the remainder transferred on April 1, 2022. The amount above represents the net impact on revenue and cost of service attributable to all of the transferred entities.
The PDGM payment under the Medicare program is also adjusted for certain variables including, but not limited to: (a) a low utilization payment adjustment if the number of visits is below an established threshold that varies based on the diagnosis of a beneficiary; (b) a partial payment if the patient transferred to another provider or the Company received a patient from another provider before completing the period of care; (c) adjustment to the admission source 32 Table of Contents of claim if it is determined that the patient had a qualifying stay in a post-acute care setting within 14 days prior to the start of a 30-day payment period; (d) the timing of the 30-day payment period provided to a patient in relation to the admission date, regardless of whether the same home health provider provided care for the entire series of episodes; (e) changes to the acuity of the patient during the previous 30-day period of care; (f) changes in the base payments established by the Medicare program; (g) adjustments to the base payments for case mix and geographic wages; and (h) recoveries of overpayments.
The PDGM payment under the Medicare program is also adjusted for certain variables including, but not limited to: (a) a low utilization payment adjustment if the number of visits is below an established threshold that varies based on the diagnosis of a beneficiary; (b) a partial payment if the patient transferred to another provider or the Company received a patient from another provider before completing the period of care; (c) adjustment to the admission source 31 Table of Contents of claim if it is determined that the patient had a qualifying stay in a post-acute care setting within 14 days prior to the start of a 30-day payment period; (d) the timing of the 30-day payment period provided to a patient in relation to the admission date, regardless of whether the same home health provider provided care for the entire series of episodes; (e) changes to the acuity of the patient during the previous 30-day period of care; (f) changes in the base payments established by the Medicare program; (g) adjustments to the base payments for case mix and geographic wages; and (h) recoveries of overpayments.
The Credit Agreement contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its independent operating subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend certain material agreements and pay certain dividends and other restricted payments.
The Amended Credit Agreement contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its independent operating subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend certain material agreements and pay certain dividends and other restricted payments.
We find that Non-GAAP Financial Measures are useful for this purpose because they do not include such costs as interest expense, income taxes, depreciation and amortization expense, which may vary from period-to-period depending upon various factors, including the method used to finance operations, the date of acquisition of a community or business, and the tax law of the state in which a business unit operates. 39 Table of Contents Non-GAAP Financial Measures have no standardized meaning defined by GAAP.
We find that Non-GAAP Financial Measures are useful for this purpose because they do not include such costs as interest expense, income taxes, depreciation and amortization expense, which may vary from period-to-period depending upon various factors, including the method used to finance operations, the date of acquisition of a community or business, and the tax law of the state in which a business unit operates. 38 Table of Contents Non-GAAP Financial Measures have no standardized meaning defined by GAAP.
Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the remaining lease term. 33 Table of Contents Critical Accounting Policies and Estimates Our discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).
Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the remaining lease term. 32 Table of Contents Critical Accounting Policies and Estimates Our discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).
See Note 14 , Income Taxes , to the Consolidated Financial Statements included elsewhere in this report filed on Form 10-K for further discussion. Comparison of Prior Year Information For a comparison of our results of operations of the fiscal year ended December 31, 2022 as compared to the year ended December 31, 2021 refer to Item 7.
See Note 14 , Income Taxes , to the Consolidated Financial Statements included elsewhere in this report filed on Form 10-K for further discussion. Comparison of Prior Year Information For a comparison of our results of operations of the fiscal year ended December 31, 2023 as compared to the year ended December 31, 2022 refer to Item 7.
The average amount of revenue for each completed 60-day home health episode generated from patients who are receiving care under Medicare reimbursement programs. 31 Table of Contents • Total hospice admissions . Total admissions of hospice patients, including new acquisitions, new admissions and recertifications. • Average hospice daily census .
The average amount of revenue for each completed 60-day home health episode generated from patients who are receiving care under Medicare reimbursement programs. 30 Table of Contents • Total hospice admissions . Total admissions of hospice patients, including new acquisitions, new admissions and recertifications. • Average hospice daily census .
Rates are set based on specific levels of care, are adjusted by a wage index to reflect healthcare labor costs across the country and are established annually through federal legislation. The following are the four levels of care provided under the hospice benefit: • Routine Home Care (“RHC”).
Rates are set based on specific levels of care, are adjusted by a wage index to reflect healthcare labor costs across the country and are established annually through federal legislation. The following are the four levels of care provided under the hospice benefit: • Routine Home Care (RHC).
The amounts reported exclude rent and depreciation and amortization expense related to such operations. (g) Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.
The amounts reported exclude rent and depreciation and amortization expense related to such operations. (e) Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.
The following table summarizes our affiliated home health and hospice agencies and senior living communities as of: 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Home health and hospice agencies 25 32 39 46 54 63 76 88 95 111 Senior living communities 15 36 36 43 50 52 54 54 49 51 Senior living units 1,587 3,184 3,184 3,434 3,820 3,963 4,127 4,127 3,500 3,588 Total number of home health, hospice, and senior living operations 40 68 75 89 104 115 130 142 144 162 Recent Activities Acquisitions.
The following table summarizes our affiliated home health and hospice agencies and senior living communities as of: 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Home health and hospice agencies 25 32 39 46 54 63 76 88 95 111 123 Senior living communities 15 36 36 43 50 52 54 54 49 51 57 Senior living units 1,587 3,184 3,184 3,434 3,820 3,963 4,127 4,127 3,500 3,588 3,960 Total number of home health, hospice, and senior living operations 40 68 75 89 104 115 130 142 144 162 180 Recent Activities Acquisitions.
Management's Discussion and Analysis of Financial Condition and Results of Operations on Form 10-K filed with the SEC on February 23, 2023. Liquidity and Capital Resources Our primary sources of liquidity are cash generated through operating activities and borrowings under our revolving credit facility.
Management's Discussion and Analysis of Financial Condition and Results of Operations on Form 10-K filed with the SEC on February 28, 2024. Liquidity and Capital Resources Our primary sources of liquidity are cash generated through operating activities and borrowings under our revolving credit facility.
The Company is permitted to prepay all or any portion of the loans under the Revolving Credit Facility prior to maturity without premium or penalty, subject to reimbursement of any LIBOR breakage costs of the lenders.
The Company is permitted to prepay all or any portion of the loans under the Amended Revolving Credit Facility prior to maturity without premium or penalty, subject to reimbursement of any SOFR breakage costs of the lenders.
Recent Accounting Pronouncements Information concerning recently issued accounting pronouncements which are not yet effective is included in Note 2, Basis of Presentation and Summary of Significant Accounting Policies in the Consolidated Financial Statements. 34 Table of Contents Results of Operations The following table sets forth details of our expenses and earnings as a percentage of total revenue for the periods indicated: Year Ended December 31, 2023 2022 2021 Total revenue 100.0 % 100.0 % 100.0 % Expense: Cost of services 80.4 79.6 79.7 Rent—cost of services 7.3 8.0 9.3 General and administrative expense 6.7 7.2 8.2 Depreciation and amortization 0.9 1.0 1.1 Loss on asset dispositions and impairment, net — 1.5 0.6 Total expenses 95.3 97.3 98.9 Income from operations 4.7 2.7 1.1 Other income (expense), net: Other income 0.1 — — Interest expense, net (1.2) (0.8) (0.5) Other expense, net (1.1) (0.8) (0.5) Income before provision for income taxes 3.6 1.9 0.6 Provision for income taxes 1.0 0.4 0.1 Net income 2.6 1.5 0.5 Less: net income (loss) attributable to noncontrolling interest 0.1 0.1 (0.1) Net income attributable to Pennant 2.5 % 1.4 % 0.6 % Year Ended December 31, 2023 2022 2021 (In thousands) Consolidated GAAP Financial Measures: Total revenue $ 544,891 $ 473,241 $ 439,694 Total expenses 519,722 460,502 434,999 Income from operations $ 25,169 $ 12,739 $ 4,695 35 Table of Contents The following table presents certain financial information regarding our reportable segments.
Recent Accounting Pronouncements Information concerning recently issued accounting pronouncements which are not yet effective is included in Note 2, Basis of Presentation and Summary of Significant Accounting Policies in the Consolidated Financial Statements. 33 Table of Contents Results of Operations The following table sets forth details of our expenses and earnings as a percentage of total revenue for the periods indicated: Year Ended December 31, 2024 2023 2022 Total revenue 100.0 % 100.0 % 100.0 % Expense: Cost of services 80.3 80.4 79.6 Rent—cost of services 6.2 7.3 8.0 General and administrative expense 7.2 6.7 7.2 Depreciation and amortization 0.9 0.9 1.0 (Gain) loss on asset dispositions and impairment, net (0.1) — 1.5 Total expenses 94.5 95.3 97.3 Income from operations 5.5 4.7 2.7 Other expense, net: Other income — 0.1 — Interest expense, net (1.0) (1.2) (0.8) Other expense, net (1.0) (1.1) (0.8) Income before provision for income taxes 4.5 3.6 1.9 Provision for income taxes 1.0 1.0 0.4 Net income 3.5 2.6 1.5 Less: net income attributable to noncontrolling interest 0.3 0.1 0.1 Net income attributable to Pennant 3.2 % 2.5 % 1.4 % Year Ended December 31, 2024 2023 2022 (In thousands) Consolidated GAAP Financial Measures: Total revenue $ 695,240 $ 544,891 $ 473,241 Total expenses 657,124 519,722 460,502 Income from operations $ 38,116 $ 25,169 $ 12,739 34 Table of Contents The following table presents certain financial information regarding our reportable segments.
The increase in the amount of cost of services was driven primarily by volume of services provided. Cost of services as a percentage of revenue increased by 80 basis points from 79.6% to 80.4% over the same time period. The increase was driven primarily by increased wages and benefits.
The increase in the amount of cost of services was driven primarily by volume of services provided and increased wages and benefits. Cost of services as a percentage of revenue decreased by 10 basis points from 80.4% to 80.3% over the same time period.
The amounts reported for the year ended December 31, 2022 include certain costs identified as redundant or non-recurring incurred by the Company for services provided by Ensign under the Transition Services Agreement, and were included in general and administrative expense. 38 Table of Contents The table below reconciles Segment Adjusted EBITDAR from Operations to Segment Adjusted EBITDA from Operations for the periods presented: Year Ended December 31, Home Health and Hospice Senior Living 2023 2022 2021 2023 2022 2021 (In thousands) Segment Adjusted EBITDAR from Operations $ 65,606 $ 61,827 $ 55,565 $ 45,294 $ 37,563 $ 37,517 Less: Rent—cost of services 5,791 5,060 4,906 33,967 32,958 35,957 Rent related to start-up and transitioning operations (313) (210) (386) (966) (1,398) (10) Segment Adjusted EBITDA from Operations $ 60,128 $ 56,977 $ 51,045 $ 12,293 $ 6,003 $ 1,570 The following discussion includes references to certain performance and valuation measures, which are non-GAAP financial measures, including Consolidated EBITDA, Consolidated Adjusted EBITDA, Segment Adjusted EBITDA from Operations, and Consolidated Adjusted EBITDAR (collectively, “Non-GAAP Financial Measures”).
The amounts reported for the year ended December 31, 2022 include certain costs identified as redundant or non-recurring incurred by the Company for services provided by Ensign under the Transition Services Agreement, and were included in general and administrative expense. 37 Table of Contents The table below reconciles Segment Adjusted EBITDAR from Operations to Segment Adjusted EBITDA from Operations for the periods presented: Year Ended December 31, Home Health and Hospice Senior Living 2024 2023 2022 2024 2023 2022 (In thousands) Segment Adjusted EBITDAR from Operations $ 87,709 $ 65,606 $ 61,827 $ 51,660 $ 45,294 $ 37,563 Less: Rent—cost of services 7,189 5,791 5,060 35,840 33,967 32,958 Rent related to start-up and transitioning operations (140) (313) (210) (393) (966) (1,398) Segment Adjusted EBITDA from Operations $ 80,660 $ 60,128 $ 56,977 $ 16,213 $ 12,293 $ 6,003 The following discussion includes references to certain performance and valuation measures, which are non-GAAP financial measures, including Consolidated EBITDA, Consolidated Adjusted EBITDA, Segment Adjusted EBITDA from Operations, and Consolidated Adjusted EBITDAR (collectively, “Non-GAAP Financial Measures”).
Rent increased 4.6% from $38.0 million to $39.8 million for the year ended December 31, 2023 compared to the year ended December 31, 2022, primarily as a result of the newly acquired senior living communities.
Rent increased 8.2% from $39.8 million to $43.0 million for the year ended December 31, 2024 compared to the year ended December 31, 2023, primarily as a result of the newly acquired senior living communities.
During 2023, we expanded our operations with the addition of three home health agencies, eight hospice agencies, two home care agencies, and two senior living communities. A subsidiary of the Company entered into a separate operations transfer agreement with the prior operator of each acquired operation as part of each transaction.
During 2024, we expanded our operations with the addition of eight home health agencies, three hospice agencies, and six senior living communities. A subsidiary of the Company entered into a separate purchase agreements with the prior operator of each acquired operation as part of each transaction.
We believe that our existing cash, cash generated through operations, and access to available borrowing capacity under our Credit Agreement, will be sufficient to provide adequate liquidity for the next twelve months for both our operating activities and opportunities for acquisition growth. 44 Table of Contents The following table presents selected data from our statement of cash flows for the periods presented: Year Ended December 31, 2023 2022 (In thousands) Net cash provided by operating activities $ 33,090 $ 9,044 Net cash used in investing activities (30,222) (24,239) Net cash provided by financing activities 1,112 12,084 Net change in cash 3,980 (3,111) Cash at beginning of year 2,079 5,190 Cash at end of year $ 6,059 $ 2,079 Year Ended December 31, 2023 Compared to the Year Ended December 31, 2022 Our net cash flow from operating activities for the year ended December 31, 2023 increased by $24.0 million when compared to the year ended December 31, 2022.
We believe that our existing cash, cash generated through operations, and access to available borrowing capacity under our Amended Credit Agreement, will be sufficient to provide adequate liquidity for the next twelve months for both our operating activities and opportunities for acquisition growth. 43 Table of Contents The following table presents selected data from our statement of cash flows for the periods presented: Year Ended December 31, 2024 2023 (In thousands) Net cash provided by operating activities $ 39,298 $ 33,090 Net cash used in investing activities (70,684) (30,222) Net cash provided by financing activities 49,573 1,112 Net change in cash 18,187 3,980 Cash at beginning of year 6,059 2,079 Cash at end of year $ 24,246 $ 6,059 Year Ended December 31, 2024 Compared to the Year Ended December 31, 2023 Our net cash flow from operating activities for the year ended December 31, 2024 increased by $6.2 million when compared to the year ended December 31, 2023.
The following table summarizes our senior living statistics for the periods indicated: Year Ended December 31, 2023 2022 Occupancy 78.5 % 75.7 % Average monthly revenue per occupied unit $ 3,969 $ 3,516 Revenue Sources Home Health and Hospice Services Home Health . We derive the majority of our home health revenue from Medicare and managed care.
The following table summarizes our senior living statistics for the periods indicated: Year Ended December 31, 2024 2023 Occupancy 78.8 % 78.5 % Average monthly revenue per occupied unit $ 4,811 $ 4,443 Revenue Sources Home Health and Hospice Services Home Health . We derive the majority of our home health revenue from Medicare and managed care.
Revenue grew due to an increase in all key performance indicators including an increase in total home health admissions of 7.6%, an increase in Medicare home health admissions of 4.0%, an increase in average Medicare revenue per 60-day completed episode of 0.1%, an increase of 6.3% in total hospice admissions, an increase of 3.9% in hospice Medicare revenue per day, and an increase of 13.5% in hospice average daily census.
Revenue grew due to an increase in almost all key performance indicators including an increase in total home health admissions of 37.3%, an increase in Medicare home health admissions of 26.9%, an increase in average Medicare revenue per 60-day completed episode of 6.0%, an increase of 25.3% in total hospice admissions, and an increase of 25.4% in hospice average daily census, while Hospice Medicare revenue per day decreased by 1.1%.
Refer to Note 2, Basis of Presentation and Summary of Significant Accounting Policies , within the Consolidated Financial Statements for further information on our critical accounting estimates and policies, which are as follows: • Self-insurance reserves - The valuation methods and assumptions used in estimating costs up to retention amounts to settle open claims of insureds and an estimate of the cost of insured claims up to retention amounts that have been incurred but not reported; • Revenue recognition - The amounts owed by private pay individuals for services and estimate of variable considerations to arrive at the transaction price, including methods and assumptions, used to determine settlements with Medicare and Medicaid adjustments due to audits and reviews; and • Acquisition accounting and goodwill - The assumptions used to allocate the purchase price paid for assets acquired and liabilities assumed in connection with our acquisitions, and the review of goodwill for impairment at the Company’s annual impairment test date or upon the occurrence of a triggering event.
The valuation methods and assumptions used in estimating costs up to retention amounts to settle open claims of insureds and an estimate of the cost of insured claims up to retention amounts that have been incurred but not reported; • Revenue recognition - The amounts owed by private pay individuals for services and estimate of variable considerations to arrive at the transaction price, including methods and assumptions, used to determine settlements with Medicare and Medicaid adjustments due to audits and reviews; and • Acquisition accounting and goodwill - The assumptions used to allocate the purchase price paid for assets acquired and liabilities assumed in connection with our acquisitions, and the review of goodwill for impairment at the Company’s annual impairment test date or upon the occurrence of a triggering event.
We calculate Consolidated Adjusted EBITDA by adjusting Consolidated EBITDA to exclude the effects of non-core business items, which for the reported periods includes, to the extent applicable: • costs at start-up operations; • share-based compensation expense; • acquisition related costs and credit allowances; 40 Table of Contents • redundant or nonrecurring costs associated with the Transition Services Agreement (as defined in Note 3, Transactions with Ensign ); • costs associated with transitioning operations ; and • unusual or non-recurring charges.
We calculate Consolidated Adjusted EBITDA by adjusting Consolidated EBITDA to exclude the effects of non-core business items, which for the reported periods includes, to the extent applicable: • costs at start-up operations; • share-based compensation expense; • acquisition related costs and credit allowances; 39 Table of Contents • costs associated with transitioning operations ; and • unusual or non-recurring charges.
Our effective tax rate for the year ended December 31, 2023 was 29.0% of earnings before income taxes compared with an effective tax rate of 18.5% for the year ended December 31, 2022. The increase in the effective tax rate is primarily due to a change in nondeductible equity compensation expenses.
Our effective tax rate for the year ended December 31, 2024 was 22.4% of earnings before income taxes compared with an effective tax rate of 29.0% for the year ended December 31, 2023. The decrease in the effective tax rate is primarily due to a change in deductible equity compensation expenses.
Segments We have two reportable segments: (1) home health and hospice services, which includes our home health, home care and hospice businesses; and (2) senior living services, which includes the operation of assisted living, independent living and memory care communities.
Segments We have two reportable segments: (1) home health and hospice services, which includes our home health, hospice, home care, and geriatric primary and palliative care businesses; and (2) senior living services, which includes our assisted living, independent living and memory care services.
General and administrative expense increased $2.7 million, or 7.9%, from $34.0 million to $36.7 million for the year ended December 31, 2023 when compared to the year ended December 31, 2022.
General and administrative expense increased $13.5 million, or 36.9%, from $36.7 million to $50.2 million for the year ended December 31, 2024 when compared to the year ended December 31, 2023.
Performance and Valuation Measures: Year Ended December 31, 2023 2022 2021 (In thousands) Consolidated Non-GAAP Financial Measures: Performance Metrics Consolidated EBITDA $ 30,107 $ 17,008 $ 10,003 Consolidated Adjusted EBITDA $ 40,716 $ 31,545 $ 26,407 Valuation Metric Consolidated Adjusted EBITDAR $ 79,196 Year Ended December 31, 2023 2022 2021 (In thousands) Segment Non-GAAP Measures: (a) Segment Adjusted EBITDA from Operations Home health and hospice services $ 60,128 $ 56,977 $ 51,045 Senior living services $ 12,293 $ 6,003 $ 1,570 (a) General and administrative expenses are not allocated to any segment for purposes of determining segment profit or loss. 37 Table of Contents The table below reconciles Consolidated Net Income to Consolidated EBITDA, Consolidated Adjusted EBITDA and Consolidated Adjusted EBITDAR for the periods presented: Year Ended December 31, 2023 2022 2021 (In thousands) Consolidated Net income $ 13,910 $ 7,243 $ 2,148 Less: Net income (loss) attributable to noncontrolling interest 531 600 (548) Add: Provision for income taxes 5,674 1,649 582 Net interest expense 5,924 3,816 1,941 Depreciation and amortization 5,130 4,900 4,784 Consolidated EBITDA 30,107 17,008 10,003 Adjustments to Consolidated EBITDA Add: Costs at start-up operations (a) 102 1,435 1,045 Share-based compensation expense (b) 5,565 3,363 10,040 Acquisition related costs and credit allowances (c) 476 731 80 Transition services costs (d) — — 2,008 Costs associated with transitioning operations (e) 612 6,103 2,835 Unusual or non-recurring charges (f) 2,575 1,297 — Rent related to items (a) and (e) above 1,279 1,608 396 Consolidated Adjusted EBITDA 40,716 31,545 26,407 Rent—cost of services 39,759 38,018 40,863 Rent related to items (a) and (e) above (1,279) (1,608) (396) Adjusted rent—cost of services 38,480 36,410 40,467 Consolidated Adjusted EBITDAR $ 79,196 (a) Represents results related to start-up operations.
Performance and Valuation Measures: Year Ended December 31, 2024 2023 2022 (In thousands) Consolidated Non-GAAP Financial Measures: Performance Metrics Consolidated EBITDA $ 42,662 $ 30,107 $ 17,008 Consolidated Adjusted EBITDA $ 53,286 $ 40,716 $ 31,545 Valuation Metric Consolidated Adjusted EBITDAR $ 95,782 Year Ended December 31, 2024 2023 2022 (In thousands) Segment Non-GAAP Measures: (a) Segment Adjusted EBITDA from Operations Home health and hospice services $ 80,660 $ 60,128 $ 56,977 Senior living services $ 16,213 $ 12,293 $ 6,003 (a) General and administrative expenses are not allocated to any segment for purposes of determining segment profit or loss. 36 Table of Contents The table below reconciles Consolidated Net Income to Consolidated EBITDA, Consolidated Adjusted EBITDA and Consolidated Adjusted EBITDAR for the periods presented: Year Ended December 31, 2024 2023 2022 (In thousands) Consolidated Net income $ 24,339 $ 13,910 $ 7,243 Less: Net income attributable to noncontrolling interest 1,780 531 600 Add: Provision for income taxes 7,028 5,674 1,649 Net interest expense 6,956 5,924 3,816 Depreciation and amortization 6,119 5,130 4,900 Consolidated EBITDA 42,662 30,107 17,008 Adjustments to Consolidated EBITDA Add: Costs at start-up operations (a) 137 102 1,435 Share-based compensation expense (b) 8,242 5,565 3,363 Acquisition related costs and credit allowances (c) 1,278 476 731 Activities associated with transitioning operations (d) (570) 612 6,103 Unusual or non-recurring charges (e) 1,004 2,575 1,297 Rent related to items (a) and (e) above 533 1,279 1,608 Consolidated Adjusted EBITDA 53,286 40,716 31,545 Rent—cost of services 43,029 39,759 38,018 Rent related to items (a) and (e) above (533) (1,279) (1,608) Adjusted rent—cost of services 42,496 38,480 36,410 Consolidated Adjusted EBITDAR $ 95,782 (a) Represents results related to start-up operations.
We operate in multiple lines of businesses including home health, hospice and senior living services across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming.
We operate in multiple lines of businesses including home health, hospice and senior living services across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. We also provide home health and hospice operational support through a management service agreement in Connecticut.
As a percentage of revenue, rent — cost of services decreased 70 basis points when compared to the year ended December 31, 2022 due to improved senior living performance. General and Administrative Expense.
As a percentage of revenue, rent — cost of services decreased 110 basis points when compared to the year ended December 31, 2023 due to improved overall sales leverage and performance. General and Administrative Expense.
Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense. (d) Non-capitalizable costs associated with acquisitions and credit allowances for amounts in dispute with the prior owners of certain acquired operations. (e) Costs identified as redundant or non-recurring incurred by the Company as a result of the Spin-Off.
Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense. (d) Non-capitalizable costs associated with acquisitions and credit allowances for amounts in dispute with the prior owners of certain acquired operations.
Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense. (c) Non-capitalizable costs associated with acquisitions and credit allowances for amounts in dispute with the prior owners of certain acquired operations. (d) Costs identified as redundant or non-recurring incurred by the Company as a result of the Spin-Off.
Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense. (c) Non-capitalizable costs associated with acquisitions and credit allowances for amounts in dispute with the prior owners of certain acquired operations.
As of December 31, 2023, our home health and hospice business provided home health, hospice and 30 Table of Contents home care services from 111 agencies operating across 13 states, and our senior living business operated 51 senior living communities throughout six states.
As of December 31, 2024, our home health and hospice business provided home health, hospice and 29 Table of Contents home care services from 123 agencies operating across 13 states, and our senior living business operated 57 senior living communities throughout seven states.
Senior Living Services Year Ended December 31, 2023 2022 Change % Change (In thousands) Cost of service $ 106,252 $ 93,650 $ 12,602 13.5 % Cost of services as a percentage of revenue 70.6 % 71.5 % (0.9) % Cost of services related to our Senior Living services segment increased $12.6 million, or 13.5%, during the year ended December 31, 2023 in response to higher occupancy and wage rate increases.
Senior Living Services Year Ended December 31, 2024 2023 Change % Change (In thousands) Cost of service $ 124,975 $ 106,252 $ 18,723 17.6 % Cost of services as a percentage of revenue 71.1 % 70.6 % 0.5 % Cost of services related to our Senior Living services segment increased $18.7 million, or 17.6%, during the year ended December 31, 2024 in response to higher occupancy, acquisitions and wage rate increases.
The following table summarizes our overall home health and hospice services statistics for the periods indicated: Year Ended December 31, 2023 2022 Home health services: Total home health admissions 43,508 40,436 Total Medicare home health admissions 19,389 18,641 Average Medicare revenue per completed 60-day home health episode (a) $ 3,533 $ 3,531 Hospice services: Total hospice admissions 9,746 9,166 Average hospice daily census 2,607 2,296 Hospice Medicare revenue per day $ 185 $ 178 (a) The year to date average for Medicare revenue per 60-day completed episode includes post period claim adjustments for prior periods.
The following table summarizes our overall home health and hospice services statistics for the periods indicated: Year Ended December 31, 2024 2023 Home health services: Total home health admissions 59,741 43,508 Total Medicare home health admissions 24,598 19,389 Average Medicare revenue per completed 60-day home health episode (a) $ 3,677 $ 3,468 Hospice services: Total hospice admissions 12,208 9,746 Average hospice daily census 3,268 2,607 Hospice Medicare revenue per day $ 183 $ 185 (a) The year to date average for Medicare revenue per 60-day completed episode includes post period claim adjustments for prior periods.
Cost of services as a percentage of revenue for the year ended December 31, 2023 increased by 140 basis points compared to the year ended December 31, 2022 primarily due to increased wages and benefits.
As a percentage of revenue, costs of service increased by 50 basis points during the year ended December 31, 2024 when compared to the year ended December 31, 2023 primarily due to increased wages and benefits. Rent—Cost of Services .
The primary drivers of this difference was a $6.7 million increase in net income, a $12.9 million net increase in cash flows from the change in operating assets and liabilities, and an increase of $4.4 million in non-cash expenses.
The primary drivers of this difference was a $10.4 million increase in net income, offset by a $2.5 million net decrease in cash flows from the change in operating assets and liabilities and a net decrease of $1.7 million in non-cash expenses.
Home Health and Hospice Services Year Ended December 31, 2023 2022 Change % Change (In thousands) Cost of service $ 331,844 $ 282,988 $ 48,856 17.3 % Cost of services as a percentage of revenue 84.1 % 82.7 % 1.4 % Cost of services related to our Home Health and Hospice services segment increased $48.9 million, or 17.3%, primarily due to increased volume of services from the growth in admissions and average daily census.
Home Health and Hospice Services Year Ended December 31, 2024 2023 Change % Change (In thousands) Cost of service $ 433,474 $ 331,844 $ 101,630 30.6 % Cost of services as a percentage of revenue 83.4 % 84.1 % (0.7) % Cost of services related to our Home Health and Hospice services segment increased $101.6 million, or 30.6%, primarily due to increased volume of services from the growth in admissions and average daily census as well as increased wages and benefits.
Year Ended December 31, 2023 Compared to the Year Ended December 31, 2022 Revenue Year Ended December 31, 2023 2022 Revenue Dollars Revenue Percentage Revenue Dollars Revenue Percentage (In thousands) Home health and hospice services Home health $ 175,044 32.1 % $ 159,858 33.8 % Hospice 194,627 35.7 160,520 33.9 Home care and other (a) 24,793 4.6 21,871 4.6 Total home health and hospice services 394,464 72.4 342,249 72.3 Senior living services 150,427 27.6 130,992 27.7 Total revenue $ 544,891 100.0 % $ 473,241 100.0 % (a) Home care and other revenue is included with home health revenue in other disclosures in this report.
Year Ended December 31, 2024 Compared to the Year Ended December 31, 2023 Revenue Year Ended December 31, 2024 2023 Revenue Dollars Revenue Percentage Revenue Dollars Revenue Percentage (In thousands) Home health and hospice services Home health $ 239,539 34.5 % $ 175,044 32.1 % Hospice 240,102 34.5 194,627 35.7 Home care and other (a) 39,843 5.7 24,793 4.6 Total home health and hospice services 519,484 74.7 394,464 72.4 Senior living services 175,756 25.3 150,427 27.6 Total revenue $ 695,240 100.0 % $ 544,891 100.0 % (a) Home care and other revenue is included with home health revenue in other disclosures in this report.
Growth in revenue was also driven by the acquisition of two senior living communities, between December 31, 2022 and December 31, 2023, resulting in an increase of $1.9 million, or 1.4% overall. 42 Table of Contents Cost of Services The following table sets forth total cost of services by each of our reportable segments for the periods indicated: Year Ended December 31, 2023 2022 Change % Change (In thousands) Home Health and Hospice $ 331,844 $ 282,988 $ 48,856 17.3 % Senior Living 106,252 93,650 12,602 13.5 Total cost of services $ 438,096 $ 376,638 $ 61,458 16.3 % Consolidated cost of services increased $61.5 million, or 16.3%, for the year ended December 31, 2023 when compared to the year ended December 31, 2022.
Growth in revenue was also driven by the acquisition of six senior living communities during the year ended December 31, 2024, and the acquisition of two senior living communities during the year ended December 31, 2023, resulting in an increase of $12.5 million, or 8.3% overall. 41 Table of Contents Cost of Services The following table sets forth total cost of services by each of our reportable segments for the periods indicated: Year Ended December 31, 2024 2023 Change % Change (In thousands) Home Health and Hospice $ 433,474 $ 331,844 $ 101,630 30.6 % Senior Living 124,975 106,252 18,723 17.6 Total cost of services $ 558,449 $ 438,096 $ 120,353 27.5 % Consolidated cost of services increased $120.4 million, or 27.5%, for the year ended December 31, 2024 when compared to the year ended December 31, 2023.
Senior Living Services Year Ended December 31, 2023 2022 Change % Change Revenue (in thousands) $ 150,427 $ 130,992 $ 19,435 14.8 % Number of communities at period end 51 49 2 4.1 Occupancy 78.5 % 75.7 % 2.8 % Average monthly revenue per occupied unit $ 3,969 $ 3,516 $ 453 12.9 % Senior living revenue increased $19.4 million, or 14.8%, for the year ended December 31, 2023 when compared to the same period in the prior year primarily due to a 12.9% increase in average monthly revenue per occupied unit and a 2.8% increase in occupancy rate between December 31, 2022 and December 31, 2023.
Senior Living Services Year Ended December 31, 2024 2023 Change % Change Revenue (in thousands) $ 175,756 $ 150,427 $ 25,329 16.8 % Number of communities at period end 57 51 6 11.8 Occupancy 78.8 % 78.5 % 0.3 % Average monthly revenue per occupied unit $ 4,811 $ 4,443 $ 368 8.3 % Senior living revenue increased $25.3 million, or 16.8%, for the year ended December 31, 2024 when compared to the same period in the prior year primarily due to a 8.3% increase in average monthly revenue per occupied unit and a 0.3% increase in occupancy rate.
We expect these metrics to vary from period to period based upon the maturity of the operations within our portfolio.
When we acquire turnaround or start-up operations, we expect that our combined metrics may be impacted. We expect these metrics to vary from period to period based upon the maturity of the operations within our portfolio.
Our consolidated revenue increased $71.7 million, or 15.1%, driven by the net organic growth of existing operations across all segments of $58.4 million or 12.3% as well as increased revenue from acquired operations of $13.3 million, or 2.8%, during the year ended December 31, 2023. 41 Table of Contents Home Health and Hospice Services Year Ended December 31, 2023 2022 Change % Change (In thousands) Home health and hospice revenue Home health services $ 175,044 $ 159,858 $ 15,186 9.5 % Hospice services 194,627 160,520 34,107 21.2 Home care and other 24,793 21,871 2,922 13.4 Total home health and hospice revenue $ 394,464 $ 342,249 $ 52,215 15.3 % Year Ended December 31, 2023 2022 Change % Change Home health services: Total home health admissions 43,508 40,436 3,072 7.6 % Total Medicare home health admissions 19,389 18,641 748 4.0 Average Medicare revenue per 60-day completed episode (a) $ 3,533 $ 3,531 $ 2 0.1 Hospice services: Total hospice admissions 9,746 9,166 580 6.3 Average daily census 2,607 2,296 311 13.5 Hospice Medicare revenue per day $ 185 $ 178 $ 7 3.9 Number of home health and hospice agencies at period end 111 95 16 16.8 % (a) The year to date average for Medicare revenue per 60-day completed episode includes post period claim adjustments for prior periods.
Our consolidated revenue increased $150.3 million, or 27.6%, driven by the net organic growth of existing operations across all segments of $59.2 million or 10.9% as well as increased revenue from acquired operations of $91.1 million, or 16.7%, during the year ended December 31, 2024. 40 Table of Contents Home Health and Hospice Services Year Ended December 31, 2024 2023 Change % Change (In thousands) Home health and hospice revenue Home health services $ 239,539 $ 175,044 $ 64,495 36.8 % Hospice services 240,102 194,627 45,475 23.4 Home care and other 39,843 24,793 15,050 60.7 Total home health and hospice revenue $ 519,484 $ 394,464 $ 125,020 31.7 % Year Ended December 31, 2024 2023 Change % Change Home health services: Total home health admissions 59,741 43,508 16,233 37.3 % Total Medicare home health admissions 24,598 19,389 5,209 26.9 Average Medicare revenue per 60-day completed episode (a) $ 3,677 $ 3,468 $ 209 6.0 Hospice services: Total hospice admissions 12,208 9,746 2,462 25.3 Average daily census 3,268 2,607 661 25.4 Hospice Medicare revenue per day $ 183 $ 185 $ (2) (1.1) Number of home health and hospice agencies at period end 123 111 12 10.8 % (a) The year to date average for Medicare revenue per 60-day completed episode includes post period claim adjustments for prior periods.
The Revolving Credit Facility is not subject to interim amortization and the Company will not be required to repay any loans under the Revolving Credit Facility prior to maturity in 2026, except that the loans may become due immediately if the Company triggers an event of default under the terms of the Credit Agreement.
The Amended Revolving Credit Facility is not subject to interim amortization and the Company will not be required to repay any loans under the Amended Revolving Credit Facility prior to maturity in 2029.
Our net cash used in investing activities for the year ended December 31, 2023 increased by $6.0 million compared to the year ended December 31, 2022, primarily driven by a $11.9 million increase in business acquisitions and other assets, offset by a $6.1 million decrease in purchases of property and equipment during the year ended December 31, 2023 compared to the year ended December 31, 2022.
Our net cash used in investing activities for the year ended December 31, 2024 increased by $40.5 million compared to the year ended December 31, 2023, primarily driven by a $40.4 million increase in business acquisitions, asset acquisitions, and escrow deposits during the year ended December 31, 2024 compared to the year ended December 31, 2023.
The improvement in these metrics resulted in net organic revenue growth of $40.8 million for the year ended December 31, 2023. Growth was also driven by the acquisition of 11 home health, home care, and hospice operations, between December 31, 2022 and December 31, 2023, resulting in an increase in revenue of $11.4 million, or 3.3% overall.
Growth was also driven by the acquisition of eleven home health and hospice operations during the year ended December 31, 2024, and the acquisition of thirteen home health, home care, and hospice operations during the year ended December 31, 2023, resulting in an increase in revenue of $78.6 million, or 19.9% overall.
Loss on asset dispositions and impairment, net decreased $6.9 million for the year ended December 31, 2023 when compared to the year ended December 31, 2022 due to the transfer of senior living communities to Ensign in 2022. Provision for Income Taxes .
(Gain) loss on asset dispositions and impairment, net is a gain of $0.7 million for the year ended December 31, 2024 compared to a loss of $0.1 million for the year ended December 31, 2023 primarily due to insurance proceeds related to one of our senior living communities. Provision for Income Taxes .
Home health and hospice revenue increased $52.2 million, or 15.3%.
Home health and hospice revenue increased $125.0 million, or 31.7%.
The increase in general and administrative expense was due to an increase of $1.5 million in share-based compensation for the year ended December 31, 2023 when compared to the year ended December 31, 2022. Depreciation and Amortization. Depreciation and amortization expense decreased slightly as a percentage of total revenue. 43 Table of Contents Loss on Asset Dispositions and Impairment, Net.
The increase in general and administrative expense was primarily due to an increase of $12.5 million in wages and benefits for the year ended December 31, 2024 when compared to the year ended December 31, 2023. Depreciation and Amortization.
The Credit Agreement provides for a revolving credit facility with a syndicate of banks with a borrowing capacity of $150.0 million (the “Revolving Credit Facility”).
Revolving Credit Facility On July 31, 2024, Pennant amended and restated its existing credit agreement (as amended, the “Amended Credit Agreement”), which provides for an increased revolving credit facility with a syndicate of banks with a borrowing capacity of $250.0 million (the “Amended Revolving Credit Facility”).
As a percentage of revenue, costs of service decreased by 90 basis points during the year ended December 31, 2023 when compared to the year ended December 31, 2022 due to cost optimization, as occupancy increases toward approximately 80.0%. Rent—Cost of Services .
Cost of services as a percentage of revenue for the year ended December 31, 2024 decreased by 70 basis points compared to the year ended December 31, 2023 primarily due to increased efficiency in our operations.
Our net cash provided by financing activities decreased by $11.0 million for the year ended December 31, 2023 when compared to the year ended December 31, 2022 primarily due to a decrease in our net borrowings.
Our net cash provided by financing activities increased by $48.5 million for the year ended December 31, 2024 when compared to the year ended December 31, 2023 primarily due to an issuance of equity through a secondary offering totaling $118.1 million offset by a net repayment of debt totaling $65.0 million and payments for deferred financing costs of $3.9 million during the year ended December 31, 2024.
Financial covenants require compliance with certain levels of leverage ratios that impact the amount of interest. As of December 31, 2023, we were in compliance with all covenants. As of December 31, 2023 we had $6.1 million of cash and $80.8 million of available borrowing capacity on our Revolving Credit Facility.
As of December 31, 2024 we had $24.2 million of cash and $245.8 million of available borrowing capacity on our Amended Revolving Credit Facility.
Though we have seen steady improvements in occupancy throughout 2022 and 2023, the highly competitive environment for senior living residents and inflationary factors will continue to impact the rate at which we return our occupancy levels in our senior living communities to pre-pandemic levels. When we acquire turnaround or start-up operations, we expect that our combined metrics may be impacted.
Although we saw steady improvements in occupancy throughout 2023 as a result of renewed consideration of senior living communities as the negative impacts of the global pandemic subsided, and stable occupancy during 2024, the highly competitive environment for senior living residents and inflationary factors will continue to impact our occupancy levels in our senior living communities.
(e) During the year ended December 31, 2023, an affiliate of the Company placed its memory care units into transition and is actively seeking to sublease the units to an unrelated third party. The amount above represents the net operating impact attributable to the units in transition.
(e) During the year ended December 31, 2023, an affiliate of the Company placed its memory care units into transition and is converting the facility into an assisted living community. We received insurance proceeds related to the property in 2024 which were recorded as a gain on asset disposition on the consolidated statements of income.
Trends We have experienced modest senior living occupancy improvement through the year ended December 31, 2023, as a result of renewed consideration of senior living communities as a home-based care setting as the negative impacts of the global pandemic have subsided.
Trends We have experienced stable senior living occupancy through the year ended December 31, 2024.
(f) During the year ended December 31, 2023, an affiliate of the Company placed its memory care units into transition and is actively seeking to sublease the units to an unrelated third party. The amount above represents the net operating impact attributable to the units in transition.
(d) During the year ended December 31, 2023, an affiliate of the Company placed its memory care units into transition and is converting the facility into an assisted living community. We received insurance proceeds related to the property in 2024 which were recorded as a gain on asset disposition on the consolidated statements of income.